I tend to agree with his assessment. Especially when it comes to the expense.
I am writing to caution readers against developing unrealistic expectations for the current generation of continuous glucose systems (Dexcom and Paradigm Real-Time).
I tend to agree with his assessment. Especially when it comes to the expense.
I am writing to caution readers against developing unrealistic expectations for the current generation of continuous glucose systems (Dexcom and Paradigm Real-Time).
Leave a Reply